共 50 条
- [45] Safety of topical calcineurin inhibitors for the treatment of atopic dermatitis PHARMACOTHERAPY, 2007, 27 (07): : 1020 - 1028
- [49] Laboratory Safety of Dupilumab in Patients Aged 6–11 Years with Severe Atopic Dermatitis: Results from a Phase III Clinical Trial Pediatric Drugs, 2021, 23 : 515 - 527